Trial intelligence / Profile preview

Alagebrium and Exercise in Healthy Elderly

NCT01417663Phase 3Completed

Sponsor
Radboud University Medical Center
Start
Nov 2008
Primary completion
Jun 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of alagebrium in arterial stiffness, endothelial dysfunction, sponsored by Radboud University Medical Center. Started Nov 2008; status: completed.

02

Drugs

alagebrium
03

Conditions

arterial stiffnessendothelial dysfunction

Beyond the preview

Go deeper on NCT01417663.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01417663.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call